Which Medications Worsen Urinary Symptoms in Men With BPH?
At a Glance
For men with BPH, decongestants such as pseudoephedrine, older antihistamines, opioids, and some antidepressants can make urination harder, while diuretics may increase urgency and nighttime trips. Do not stop prescriptions without medical advice; complete inability to urinate is an emergency.
Yes, several common prescription and over-the-counter medications can worsen symptoms of an enlarged prostate (often called a prostatic adenoma or BPH).
Important Safety Warning: If you cannot urinate at all, especially if you have painful swelling in your lower abdomen, seek emergency medical care immediately. This is a medical emergency called acute urinary retention, and you should not wait for a routine appointment [1].
Before blaming a medication, remember that a sudden change in urination can also be caused by an infection, constipation, or worsening of the BPH itself [2]. However, if your symptoms worsened after starting a new drug or changing a dose, your medications should be reviewed. Never stop taking essential prescriptions (like those for heart disease or depression) without professional guidance [1].
Medicines That Can Make It Harder to Empty Your Bladder
These drugs can worsen voiding symptoms (difficulty starting your stream, a weak stream, or a feeling that your bladder is not completely empty) [3].
- Decongestants (Cold and Sinus Meds): Medicines containing pseudoephedrine or phenylephrine (often marked with a “-D” on the package) work by shrinking blood vessels in your nose. Unfortunately, they stimulate the same “adrenergic” receptors that control the smooth muscle in your prostate and the opening of your bladder [4]. This can cause the prostate to tighten up, increasing resistance and making it harder to urinate [5].
- Older Antihistamines (Allergy and Sleep Aids): First-generation antihistamines (like diphenhydramine or doxylamine) have strong anticholinergic effects, meaning they interfere with the nerve signals that tell your bladder muscle to squeeze [6]. When your bladder muscle cannot squeeze strongly enough to push past an enlarged prostate, urine gets left behind (increased post-void residual) and your risk of acute urinary retention goes up [7][8]. Newer, second-generation allergy medicines typically have much less of this effect.
- Certain Antidepressants: While it is uncommon, some antidepressants can cause urinary retention in men with BPH. Analysis of adverse event reports has linked drugs like duloxetine, mirtazapine, and maprotiline to urinary retention signals, though the overall risk remains low [9]. Rare case reports have also noted retention with escitalopram [10][11]. Risk varies by person and drug; if you notice voiding difficulty, do not abruptly stop your medicine—contact your prescriber to discuss alternatives.
- Opioid Pain Relievers: Prescription painkillers (like those used after surgery) can disrupt the nerves that tell your bladder it is full or time to empty. Opioids are a known risk factor for urinary retention, especially in men with BPH [12][13].
A note on Overactive Bladder (OAB) treatments: If you have severe storage symptoms (urgency, frequency, and waking up at night), your doctor might prescribe OAB medications like antimuscarinics alongside your BPH treatment [14]. This can be safe for selected patients, but because these drugs relax the bladder, they require careful supervision [15]. Your doctor will likely measure your residual urine before and after starting the drug to ensure you are emptying safely [2]. Sometimes, an alternative called a beta-3 agonist is used [14].
Medicines That Increase Urine Production (Diuretics)
If you take a diuretic (a “water pill” prescribed for blood pressure, heart failure, or swelling), it will make your body produce a larger volume of urine.
While diuretics generally do not cause the prostate to tighten or directly block the flow of urine [16], they can make your storage symptoms feel much worse [17]. A bladder that is already struggling to empty may become quickly overwhelmed by the extra fluid, leading to severe urgency or nighttime bathroom trips (nocturia) [2]. Adjusting the timing of your dose to earlier in the day often helps, but you must ask your prescribing doctor first—changing the timing of a diuretic on your own could interfere with your heart failure or blood pressure control.
Preparing for Your Doctor’s Visit
Medication-related urinary symptoms are common, especially in older men taking multiple drugs [6][9]. If you suspect a medication is affecting your bladder, make a list of every prescription, over-the-counter medicine, supplement, and sleep aid you take, including their exact doses and when you started them, and bring it to your next appointment [1].
Common questions in this guide
Which cold medicines should men with BPH be careful with?
Can allergy or sleep medicines cause urinary retention with BPH?
Can antidepressants and opioid pain medicines worsen BPH symptoms?
Do water pills make an enlarged prostate worse?
When should difficulty urinating with BPH be treated as an emergency?
Are overactive bladder medicines safe for people with BPH?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Medication effects on urination
Could any of my current medications be making my urinary symptoms worse?
Decongestants and antihistamines
Should I ask my doctor whether decongestants or first-generation antihistamines could affect my urination?
Diuretics and nighttime urination
Could changing when I take my diuretic help with nighttime bathroom trips?
Related questions
Show more
Get notified when new evidence is published on prostatic adenoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Urinary Retention in Adults: Evaluation and Initial Management.
Serlin DC, Heidelbaugh JJ, Stoffel JT
American family physician 2018; (98(8)):496-503.
PMID: 30277739 - 2
Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.
Homma Y, Gotoh M, Kawauchi A, et al.
International journal of urology : official journal of the Japanese Urological Association 2017; (24(10)):716-729 doi:10.1111/iju.13401.
PMID: 28748576 - 3
Convective Water Vapor Energy for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.
DeLay KJ, McVary KT
The Urologic clinics of North America 2016; (43(3)):371-5.
PMID: 27476129 - 4
Pathophysiological mechanisms of benign prostatic obstruction in men with small prostate volume and the emerging role of ultra-minimally invasive prostatic urethral dilation: a narrative review.
Shen K, Zhang D, Yu L
Frontiers in molecular biosciences 2026; (13()):1886121 doi:10.3389/fmolb.2026.1886121.
PMID: 42620960 - 5
Relevance of STIM/Orai Calcium Entry System Hyperactivation in Human Prostate Contractility in Benign Prostate Hyperplasia.
La Fuente JM, El Assar M, Fernández A, et al.
International journal of molecular sciences 2025; (26(18)) doi:10.3390/ijms26188985.
PMID: 41009555 - 6
Potentially inappropriate prescriptions of anticholinergic drugs in patients with benign prostatic hyperplasia.
Valladales-Restrepo LF, Machado-Alba JE
The aging male : the official journal of the International Society for the Study of the Aging Male 2020; (23(5)):785-792 doi:10.1080/13685538.2019.1595572.
PMID: 30955405 - 7
Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis.
Lenfant L, Pinar U, Roupret M, et al.
The Journal of urology 2023; (209(2)):314-324 doi:10.1097/JU.0000000000003077.
PMID: 36395428 - 8
Efficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis.
Kim HJ, Sun HY, Choi H, et al.
PloS one 2017; (12(1)):e0169248 doi:10.1371/journal.pone.0169248.
PMID: 28072862 - 9
A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database.
Uekusa S, Mogi K, Ota Y, et al.
Drugs - real world outcomes 2024; (11(4)):691-700 doi:10.1007/s40801-024-00465-8.
PMID: 39537981 - 10
Escitalopram-Associated Acute Urinary Retention in Elderly Men With Known or Latent Benign Prostatic Hyperplasia: A Case Series.
Ferentinos P, Margaritis D, Douzenis A
Clinical neuropharmacology 2016; (39(6)):327-328 doi:10.1097/WNF.0000000000000194.
PMID: 27764053 - 11
Urinary retention caused by mirtazapine in a patient with geriatric depression: A case report.
Tsai LH, Lin JW, Lee MS, Huang Y
The Journal of international medical research 2025; (53(7)):3000605251353195 doi:10.1177/03000605251353195.
PMID: 40613657 - 12
Urinary retention after total joint arthroplasty of hip and knee: Systematic review.
Cha YH, Lee YK, Won SH, et al.
Journal of orthopaedic surgery (Hong Kong) 2020; (28(1)):2309499020905134 doi:10.1177/2309499020905134.
PMID: 32114894 - 13
An Additive Mix? Acute Urinary Retention in a Patient With Benign Prostatic Hyperplasia Treated With Suboxone, Lurasidone, and Trazodone.
Kahn B, Boazak M, Ragazino J, et al.
Focus (American Psychiatric Publishing) 2018; (16(3)):292-298 doi:10.1176/appi.focus.20180007.
PMID: 31975924 - 14
Non-interventional and medical management of lower urinary tract symptoms related to benign prostatic hyperplasia in men: Guidelines of the French LUTS Committee (CTMH).
Anract J, Klein C, Sarrazin C, et al.
The French journal of urology 2025; (35(11)):102952 doi:10.1016/j.fjurol.2025.102952.
PMID: 41271371 - 15
Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasia.
De Nunzio C, Presicce F, Tubaro A
Drugs of today (Barcelona, Spain : 1998) 2016; (52(9)):501-517 doi:10.1358/dot.2016.52.9.2525739.
PMID: 27883117 - 16
Benign prostatic hyperplasia.
Chughtai B, Forde JC, Thomas DD, et al.
Nature reviews. Disease primers 2016; (2()):16031 doi:10.1038/nrdp.2016.31.
PMID: 27147135 - 17
Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trials.
Vlachopoulos C, Oelke M, Maggi M, et al.
International journal of clinical practice 2015; (69(12)):1496-507 doi:10.1111/ijcp.12722.
PMID: 26299520
This page is for informational purposes only and does not replace medical advice. Do not stop or change prescription medicines without speaking with your prescriber, and seek emergency care if you cannot urinate.